PYA Waltman Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.78M | Buy |
20,375
+1,871
| +10% | +$347K | 1.09% | 22 |
|
|
2025
Q1 | $3.88M | Buy |
18,504
+51
| +0.3% | +$10.7K | 1.22% | 18 |
|
|
2024
Q4 | $3.28M | Buy |
18,453
+402
| +2% | +$71.4K | 1.06% | 23 |
|
|
2024
Q3 | $3.56M | Buy |
18,051
+846
| +5% | +$167K | 1.16% | 22 |
|
|
2024
Q2 | $2.95M | Buy |
17,205
+1,117
| +7% | +$192K | 1.08% | 24 |
|
|
2024
Q1 | $2.93M | Buy |
16,088
+282
| +2% | +$51.4K | 1.09% | 20 |
|
|
2023
Q4 | $2.45M | Buy |
15,806
+1,939
| +14% | +$300K | 1.02% | 23 |
|
|
2023
Q3 | $2.07M | Buy |
13,867
+3,106
| +29% | +$463K | 0.88% | 24 |
|
|
2023
Q2 | $1.64M | Buy |
10,761
+2,869
| +36% | +$437K | 0.71% | 24 |
|
|
2023
Q1 | $1.26M | Buy |
7,892
+2,454
| +45% | +$391K | 0.62% | 24 |
|
|
2022
Q4 | $879K | Buy |
5,438
+934
| +21% | +$151K | 0.46% | 25 |
|
|
2022
Q3 | $604K | Buy |
4,504
+2,556
| +131% | +$343K | 0.35% | 27 |
|
|
2022
Q2 | $298K | Buy |
1,948
+646
| +50% | +$98.8K | 0.17% | 34 |
|
|
2022
Q1 | $211K | Buy |
1,302
+550
| +73% | +$89.1K | 0.1% | 43 |
|
|
2021
Q4 | $102K | Buy |
+752
| New | +$102K | 0.05% | 68 |
|